New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Washington D.C. [USA], Mar 20 (ANI): As experts from across the world scramble to find a cure for the deadly COVID-19, a few pre-existing drugs have shown positive signs in treating the fast-spreading disease.
New Delhi [India], Feb 5 (ANI): In a significant move, the India Council of Medical Research (ICMR) has sought an emergency approval from Central Drug Control Organisation (CDCSO) to use combination of anti-HIV drugs- 'Lopinavir and Ritonavir' tablets for the treatment of novel coronavirus (